UMass Medical School researchers to start trial of Moderna COVID-19 vaccine in teens By Susan E.W. Spencer January 26, 2021
UMass Medical School researchers are about to start enrolling adolescents ages 12 through 17 in a clinical trial to test the COVID-19 mRNA vaccine made by Moderna. The vaccine has already been authorized for emergency use in adults 18 years or older by the U.S. Food and Drug Administration. This is the first it is being tested in a younger population.
Moderna expects to enroll 3,000 adolescents at up to 15 sites nationwide. Enrollment in the trial, called TeenCove, is expected to start at the Medical School in early February. Adolescents and their families can visit the TeenCOVEStudy.com website for more information and to indicate their interest in participating.